Pilocarpine toxicity in retinal ganglion cells

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 3, 1999, Pages 813-816

  Vorwerk, Christian K ^a   Simon, Perikles ^a   Gorla, Madhu ^a   Katowitz, William ^a   Zurakowski, David ^a   Levin, Leonard A ^a   Dreyer, Evan B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR FLOW; ARTICLE; CATARACTOGENESIS; CELL VIABILITY; CILIARY MUSCLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; INTRAOCULAR PRESSURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA DETACHMENT; RETINA GANGLION CELL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; INOSITOL; LITHIUM; PILOCARPINE; RATS; RATS, LONG-EVANS; RETINAL GANGLION CELLS;

EID: 0033045899     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Epstein DL, Allingham RR, Schuman JS. Chandler and Grant's Glaucoma. Baltimore: Williams & Wilkins; 1997:157-159.
2. Turski WA, Cavalheiro EA, Schwarz M, Czuczwar SJ, Kleinrok Z, Turski L. Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study. Behav Brain Res. 1983;9:315-335.
3. Honchar MP, Olney JW, Sherman WR. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science. 1983;220:323-325.
4. Vazquez AJ, Krip G, Pinsky C. Evidence for a muscarinic inhibitory mechanism in the cerebral cortex. Exp Neurol. 1969;23:318-331.
5. Turkanis SA, Esplin DW. Evidence for the release and depletion of the postsynaptic inhibitory transmitter by pilocarpine. Arch Int Pharmacodyn Ther. 1968;173:195-200.
6. Olney JW, Gubareff T, Labruyere J. Seizure-related brain damage induced by cholinergic agents. Nature. 1983;301:520-522.
7. Williams MB, Jope RS. Modulation by inositol of cholinergic-and serotonergic-induced seizures in lithium-treated rats Brain Res. 1995;685:169-178.
8. Agam G, Shapiro Y, Bersudsky Y, Kofman O, Belmaker RH. High-dose peripheral inositol raises brain inositol levels and reverses behavioral effects of inositol depletion by lithium. Pharmacol Biochem Behav. 1994;49:341-343.
9. Bersudsky Y, Kaplan Z, Shapiro Y, Agam G, Kofman O, Belmaker RH. Behavioral evidence for the existence of two pools of cellular inositol. Eur Neuropsychopharmacol. 1994;4:463-467.
10. Hirvonen MR, Paljarvi L, Savolainen KM. Sustained effects of pilocarpine-induced convulsions on brain inositol and inositol monophosphate levels and brain morphology in young and old male rats. Toxicol Appl Pharmacol. 1993;122:290-299.
11. Jope RS, Song L, Kolasa K. Inositol trisphosphate, cyclic AMP, and cyclic GMP in rat brain regions after lithium and seizures. Biol Psychiatry. 1992;31:505-514.
12. Jope RS, Kolasa K, Song L, Ormandy GC. Seizures selectively impair agonist-stimulated phosphoinositide hydrolysis without affecting protein kinase C activity in rat brain. Neurotoxicology. 1992;13:389-400.
13. Kofman O, Belmaker RH, Grisaru N, et al. Myo-inositol attenuates two specific behavioral effects of acute lithium in rats. Psychopharmacol Bull. 1991;27:185-190.
14. Kofman O, Bersudsky Y, Vinnitsky I, Alpert C, Belmaker RH. The effect of peripheral inositol injection on rat motor activity models of depression. Isr J Med Sci. 1993;29:580-586.
15. Kofman O, Sherman WR, Katz V, Belmaker RH. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacology (Berl). 1993;110:229-234.
16. Patishi Y, Belmaker RH, Bersudsky Y, Kofman O. A comparison of the ability of myo-inositol and epi-inositol to attenuate lithium-pilocarpine seizures in rats. Biol Psychiatry. 1996;39:829-832.
17. Patishi Y, Agam G, Tardov M, Kofman O, Belmaker RH. Lack of effect of ECS on rat brain inositol monophosphatase activity and inositol levels and of i.c.v. inositol on ictal and post-ictal length. J Psychiatr Res. 1996;30:39-43.
18. Savolainen KM, Hirvonen MR. Second messengers in cholinergic-induced convulsions and neuronal injury. Toxicol Lett. 1992;64-65:437-445.
19. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA. HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science. 1990;248:364-367.
20. Liu Y, Sonek GJ, Berns MW, Tromberg BJ. Physiological monitoring of optically trapped cells: assessing the effects of confinement by 1064-nm laser tweezers using microfluorometry Biophys J. 1996;71:2158-2167.
21. Miccoli L, Oudard S, Sureau F, Poirson F, Dutrillaux B, Poupon MF. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J. 1996;313:957-962.
22. Sokal RR, Rohlf FJ. Biometry. 3rd ed. New York: WH Freeman; 1995:491-493.
23. Kofman O, Belmaker RH. Ziskind-Somerfeld Research Award. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biol Psychiatry. 1993;34:839-852.
24. Gonzales RA, Crews FT. Characterization of the cholinergic stimulation of phosphoinositide hydrolysis in rat brain slices. J Neurosci. 1984;4:3120-3127.
25. Honda K, Takano Y, Kamiya H. The mechanism of muscarinic agonist-stimulated inositol phosphate formation in permeabilized ileal smooth muscle. Jpn J Pharmacol. 1994;65:275-280.
26. Sendelbeck L, Moore D, Urquhart J. Comparative administration of pilocarpine in ocular tissues of the rabbit during administration by eyedrop or by membrane-controlled delivery systems Am J Ophthalmol. 1975;80:274-283.
27. Krohn DL, Breitfeller JM. Transcorneal flux of topical pilocarpine to the human aqueous. Am J Ophthalmol. 1979;87:50-56.